Article
Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.
International journal of cancer - 29 Mar 1995
Aagaard L, Lukas J, Bartkova J, Kjerulff A A, Strauss M, Bartek J
Abstract excerpt
The p16Ink4/MTS1/CDKN2 is a cell-cycle regulatory inhibitor of cyclin-dependent kinase 4 (cdk4), and a candidate tumour suppressor whose gene on chromosome band 9p21 is frequently deleted or mutated in diverse types of cancer. Cdk4 in association with its D-type cyclin partners, together with p16...
Topics
- Carrier Proteins
- Cell Cycle
- Chromosome Aberrations
- Cyclin-Dependent Kinase 4
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinases
- Genes, Retinoblastoma
- Humans
- Mutation
- Neoplasms
- Polymerase Chain Reaction
